Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cholangitis

• Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
• Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
• Study of [14C]CS0159 in China Healthy Subjects
• A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
• IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
• Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
• CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
• CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
• Vancomycin in Primary Sclerosing Cholangitis in Italy
• Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis
• Detoxification of the Liver In PSC (Dolphin)
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
• Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
• Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
• Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
• Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
• A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.
• Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese
• Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
• Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
• Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Patients With PBC
• Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis
• Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
• Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
• Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
• A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
• Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis
• An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
• Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
• A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
• A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
• Clinical Research of Reducing Medication Regimen for Ursodeoxycholic Acid in Treatment of Stable Primary Biliary Cholangitis
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
• Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
• Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
• Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
• Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
• Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
• Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
• Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy
• Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)
• Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
• Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
• A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC
• Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus
• Combination Antiretroviral Therapy (cART) for PBC
• Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis
• norUrsodeoxycholic Acid vs Placebo in PSC
• A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
• Vidofludimus Calcium for Primary Sclerosing Cholangitis
• Vancomycin for Primary Sclerosing Cholangitis
• A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
• Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
• Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
• Probiotics in PBC Patients of Poor Response to UDCA
• Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
• A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
• An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
• A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
• A POC and Dose-Ranging Study of HTD1801 in PSC Patients
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
• Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.
• A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
• Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
• Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis
• Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid
• Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
• A Study of HTD1801 in Healthy Subjects
• Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
• Antibiotics to Decrease Post ERCP Cholangitis
• "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children"
• Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients
• A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
• Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis
• Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
• Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
• Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis
• Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
• Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
• Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
• A Study of Oral Hymecromone and Hyaluronan Synthesis
• Treatment of IgG4-Related Disease With Revlimid and Rituximab
• The Effect of Bezafibrate on Cholestatic Itch
• PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis
• Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography
• Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
• A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
• A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
• A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
• Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
• Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
• Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP
• Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study
• Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
• The INFECIR-2 Albumin Prevention Study
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
• Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
• Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
• A Pilot Study of Xifaxan to Treat Patients With PSC
• Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
• Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
• Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
• Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
• Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting
• Pilot Study of Fenofibrate for PSC
• Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
• A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
• Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
• Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)
• Minocycline in Primary Sclerosing Cholangitis (PSC)
• Evaluation of DHA for the Treatment of PSC
• Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy
• Probiotics in Patients With Primary Sclerosing Cholangitis
• Trial of High-dose Urso in Primary Sclerosing Cholangitis
• Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
• Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis